A+ A A-

Information Accessibility Statement
Site Colors Display (* Modern browsers like Chrome & Firefox) Normal Display Adjusted for color blinded Adjusted for hard vision Close

‹ › ×

Perry Elyassi

2nd year, 4 year program

Dr. Michael Gurevich- Neurogenomic Lab, Multiple Sclerosis

Molecular biomarkers of disease activity in Multiple

Sclerosis for prediction of clinical outcome and disease monitoring. Combination of gene expression and MRI approaches

מוקד שירות אנגלית

Quality Metrics

donation - אתר אנגלית

MOVIES - אתר אנגלית